Results 101 to 110 of about 289,464 (193)

Cost-utility analysis of sequential therapies for pediatric-onset eosinophilic esophagitis. [PDF]

J Pediatr Gastroenterol Nutr
Arcos-Machancoses JV, Crehuá-Gaudiza E, Martínez-Costa C.   +2 more
europepmc   +1 more source

Cost-Utility Analysis of Rituximab vs Mycophenolate Mofetil for the Treatment of Pemphigus Vulgaris

, 2022
Michelle K. Y. Chen, Ravi Vissapragada, Norma B. Bulamu, Monisha Gupta, Victoria P. Werth, Deshan F. Sebaratnam   +5 more
openalex   +2 more sources

Cost-utility analysis of screening and cognitive behavioral therapy compared to usual care for postpartum depression. [PDF]

BMC Psychiatry
Wang B, Shen S, Lok KY, Lin J, Smith RD.
europepmc   +1 more source

Cost–Utility Analysis of Supervised Inspiratory Muscle Training Added to Post-COVID Rehabilitation Program in the Public Health System of Brazil [PDF]

Guilherme Pacheco Modesto, Aline Loschi Soria, Luís Vicente Franco de Oliveira, Everton Nunes da Silva, Graziella França Bernardelli Cipriano, Gerson Cipriano, Vinicius Maldaner   +6 more
openalex   +1 more source

Multinational cost-utility analysis of panel-based pharmacogenetics-guided treatment of patients enrolled in the U-PGx PREPARE study. [PDF]

EClinicalMedicine
Fragoulakis V, Swen JJ, Koufaki MI, Blagec K, Blagus T, Böhringer S, Cambon-Thomsen A, Cecchin E, Cheung KC, Deneer VHM, Dupui M, Jonsson S, Joefield-Roka C, Just KS, Karlsson MO, Konta L, Koopmann R, Kriek M, Lehr T, Manson LEN, Rial-Sebbag E, Rollinson V, Roncato R, Samwald M, Schaeffeler E, Skokou M, Schwab M, Steinberger D, Stingl JC, Tremmel R, Turner RM, van Rhenen MH, van der Wouden CH, Dávila-Fajardo CL, Dolžan V, Pirmohamed M, Sunder-Plassmann G, Toffoli G, Guchelaar HJ, Patrinos GP, Mitropoulou C.   +40 more
europepmc   +1 more source

Cost-utility analysis of omalizumab for the treatment of chronic spontaneous urticaria in China. [PDF]

Cost Eff Resour Alloc
Huang Y, Yuan H, Huang Z.
europepmc   +1 more source

A cost-utility analysis for return-to-work interventions comparing alternative methods for handling missing health-related quality of life data. [PDF]

J Rehabil Med
Nguyen C, Burger EA, Aasdahl L, Morgante N, Fimland MS, Bjørnelv GMW.   +5 more
europepmc   +1 more source

A cost-utility analysis of Glecaprevir/Pibrentasvir versus Sofosbuvir/Daclatasvir and Sofosbuvir/Velpatasvir for treatment of hepatitis C in Iran. [PDF]

Cost Eff Resour Alloc
Jafari M, Mehdizadeh P, Keshavarz K, Teymourzadeh E, Abyazi MA, Alavian SM, Pouria A.   +6 more
europepmc   +1 more source

Cost-utility analysis tool

A tool to quantify the anticipated net gain in predictive accuracy for additional sources of data Software implementation of the tool in R.
openaire   +1 more source

Cost–utility analysis of screening for colorectal precancerous lesions and cancer in Beijing: A case–control study

, 2019
Ayan Mao, Wuqi Qiu, Hanyue Ding, Lian Wen, P. Dong, Yujie Yang, Xuan Cheng   +6 more
openalex   +1 more source